Your Reliable Partner for Cardiovascular Model Construction

It is found that abnormalities in glycation and glycosylation may impair protein function and stability, thus contributing to the onset and progression of different diseases, such as cardiovascular disease, kidney disease, and others. Disease modeling is an important tool for cardiovascular and other disease research. CD BioGlyco provides efficient cardiovascular model construction service based on our strong model construction team and rich experience in Glycobiology Disease Model Construction. We have the expertise and flexibility to develop in vivo models to meet the specific needs of our clients.

As a leader in the field of Glycobiology Disease Model Development, we construct a variety of cardiovascular models (rat, mouse, etc.) for our clients' needs through a variety of efficient modeling techniques. We have excellent analytical capabilities including blood pressure monitoring, cardiac hypertrophy, cardiac dysfunction, and vascular sclerosis. All experimental models are rigorously tested according to standards. These models constructed are a versatile tool that will help to deepen the study of the correlation between the mechanisms of cardiovascular disease onset and glycosylation, among others. In addition, these models are used for drug development and screening.

• Anti-thrombotic model construction service
  The anti-thrombotic model is important for understanding the mechanism of arterial and venous thrombosis, searching for new anti-thrombotic therapeutic targets, researching preventive and therapeutic methods, etc. CD BioGlyco provides a high-quality anti-thrombotic model construction service to help clients' research.
• Hypertension model construction service
  Hypertension is a multifactorial, multigenic disease that is associated with a variety of factors including abnormal glycosylation. The hypertension model is an efficient tool for exploration. CD BioGlyco provides a personalized hypertension model construction service. We carry out a large number of experiments to ensure the construction of an ideal hypotension model.

Publication Data

Frequently Asked Questions

• What is the relationship between glycosylation and cardiovascular disease?
  Glycosylation is a universal modification pathway of proteins that plays an important role in physiological activities such as cell-to-cell interactions, immune responses, signaling, and adhesion. It has been found that abnormalities in the glycosylation process can lead to alterations in findings such as the glycoproteins produced, which can affect various physiological activities and may seriously lead to cardiovascular disease. For example, altered O-GlcNAcylation may lead to the onset and development of diseases such as cardiovascular remodeling.
• What are the current animal models used for hypertension disease research?
  Researchers have developed various animal models through exploration, including genetic and non-genetic models to study the pathogenesis and treatment of hypertension disease efficiently. Genetic models include genotype-driven animal models and phenotype-driven animal models. Non-genetic models include animal models obtained through non-genetic means of intervention. These models help to enrich the understanding of the pathobiology of hypertension, the mechanisms of disease development, and so on.

Applications of Cardiovascular Model Construction Service

• Drug development and testing: Cardiovascular models are used to simulate the effects of new drugs on the heart, circulatory system, and more. The drug development process is accelerated by detecting drug responses in the model, evaluating efficacy, and identifying potential side effects.
• Pathogenesis studies: Cardiovascular models are used in studies of disease mechanisms and pathophysiology related to glycosylation to gain insight into disease progression and identify biomarkers.
• Therapeutic target research: Cardiovascular models are used to study glycosylation changes such as O-GlcNActylation in vivo, and to study the correlation between glycosylation abnormalities and diseases to discover new therapeutic targets.

Advantages of Cardiovascular Model Construction Service

• With years of experience in gene editing and animal model construction, we provide efficient cardiovascular model construction services for disease research.
• We have a strict quality control system and conduct real-time testing during the cardiovascular model construction process to ensure that the project is completed efficiently.
• We provide personalized cardiovascular model construction solutions to meet the specific needs of researchers.

CD BioGlyco has extensive experience in the development of various glycosylation-related disease models. We are constantly updating our experimental techniques to ensure that we deliver high-quality cardiovascular models. Please feel free to contact us to learn more about our cardiovascular model construction services, if you are interested in our services or need to discuss the details of these model constructs further.